Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

1.4K
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
1.4K
Causality in Epidemiology01:21

Causality in Epidemiology

1.8K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.8K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

505
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
505
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

679
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
679
Cancer Survival Analysis01:21

Cancer Survival Analysis

808
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
808

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Cutting Edge: Interventional Strategies for Pain Management.

Physical medicine and rehabilitation clinics of North America·2026
Same author

An explainable multi-stage framework for brain tumor classification using hybrid feature fusion and EfficientNetB5 model.

Scientific reports·2026
Same author

A gated task-attentive multi-task network for unified retinal image analysis.

Scientific reports·2026
Same author

Characteristics and Outcomes of Patients With Malignancies Prior to Colorectal Cancer: A Propensity Score Matched Analysis.

Journal of gastrointestinal cancer·2026
Same author

Glucagon-like Peptide-1 Receptor Agonist Therapy and Risk of Pulmonary and Systemic Infections in Diabetic Gastroparesis: A Propensity-Matched Cohort Study.

Advances in respiratory medicine·2026
Same author

Morphology-guided attention networks for explainable skin cancer detection under clinical uncertainty.

Frontiers in oncology·2026

Related Experiment Video

Updated: Jul 20, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Explainable and uncertainty-aware ensemble framework with causal analysis for breast cancer detection.

Muhammad Zaheer Sajid1, Muhammad Fareed Hamid2, Imran Qureshi3

  • 1Department of Electrical and Computer Engineering, George Mason University, Fairfax, VA, United States.

Frontiers in Oncology
|March 9, 2026
PubMed
Summary

This study introduces an AI framework for breast cancer prediction, enhancing accuracy and trust by combining uncertainty estimation and causal explanations. The model provides reliable diagnostic insights for clinicians.

Keywords:
SHAP explainabilitybreast cancer predictioncausal interpretabilityclinical decision supportensemble learninguncertainty quantification

More Related Videos

X-ray Visualization of Intraductal Ethanol-based Ablative Infusion for Prevention of Breast Cancer in Rabbit Models
08:16

X-ray Visualization of Intraductal Ethanol-based Ablative Infusion for Prevention of Breast Cancer in Rabbit Models

Published on: September 12, 2025

Related Experiment Videos

Last Updated: Jul 20, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

X-ray Visualization of Intraductal Ethanol-based Ablative Infusion for Prevention of Breast Cancer in Rabbit Models
08:16

X-ray Visualization of Intraductal Ethanol-based Ablative Infusion for Prevention of Breast Cancer in Rabbit Models

Published on: September 12, 2025

Area of Science:

  • Oncology
  • Artificial Intelligence
  • Medical Informatics

Background:

  • Breast cancer is a leading cause of cancer mortality globally, characterized by aggressive growth and metastasis.
  • Current machine learning models for breast cancer diagnosis often lack robust uncertainty handling and clear explainability.
  • Addressing these limitations is crucial for improving diagnostic accuracy and clinical trust.

Purpose of the Study:

  • To develop an integrated framework for breast cancer prediction that incorporates uncertainty-aware ensemble learning and causal feature analysis.
  • To enhance the interpretability and trustworthiness of machine learning models in clinical decision-making.
  • To provide clinicians with clear confidence levels for predictions, reducing diagnostic errors.

Main Methods:

  • Utilized an ensemble of Light Gradient Boosting Machine (LightGBM), random forest, and gradient boosting classifiers with integrated uncertainty estimation.
  • Employed causal analysis to identify potential clinical confounders.
  • Integrated multimodal explainability techniques including SHAP (Shapley Additive Explanations), permutation importance, and feature attribution.

Main Results:

  • Achieved high performance on two public datasets, with AUCs up to 0.99 and accuracies up to 0.98%.
  • Demonstrated 100% precision for high-confidence predictions on one dataset, with no false positives.
  • Causal analysis identified key confounders such as lymph node involvement, tumor size, and metastasis; fairness tests indicated balanced performance across demographic groups.

Conclusions:

  • The proposed framework effectively combines uncertainty estimation and causal interpretability for accurate and trustworthy breast cancer prediction.
  • The model offers clinicians transparent decision support with explicit confidence levels, enhancing reliability in clinical settings.
  • This approach has the potential to significantly reduce diagnostic errors and improve patient outcomes.